Patent · US Active

Nalmefene hydrochloride dihydrate

US8530495B2 · kind B2 · utility

4Cited by

0References

15Claims

0Family size

Assignees

H. LUNDBECK A/S · DK
Bioei Therapies Corp · FI

Inventors

Heidi Lopez de Diego · Nærum, DK
Carla De Faveri · Isola di Terranegra, IT
Florian Huber · Grassau, DE

Key dates

Filing date	Dec 4, 2009
Grant date	Sep 10, 2013
Priority date	—
Expiry date	Aug 8, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the Nalmefene hydrochloride dihydrate, methods of manufacturing Nalmefene hydrochloride dihydrate, a pharmaceutical composition comprising Nalmefene hydrochloride dihydrate and a method of treatment comprising administering Nalmefene hydrochloride dihydrate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.